Cargando…

Nursing in patients with hematological malignancies

Detalles Bibliográficos
Autores principales:	Geres, Hana, Kotchetkov, Rouslan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204609/ https://www.ncbi.nlm.nih.gov/pubmed/32382410 http://dx.doi.org/10.2217/ijh-2020-0011

Ejemplares similares

Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis
por: Geres, Hana, et al.
Publicado: (2023)

Case Report: Effects of multiple myeloma therapy on essential thrombocythemia and vice versa: a case of synchronous dual hematological malignancy
por: Krishnan, Nupur, et al.
Publicado: (2023)

Ventricular Tachycardia in Pregnant Patients
por: Kotchetkov, Rouslan, et al.
Publicado: (2010)

Lymphocytosis with Smudge Cells Is Not Equivalent to Chronic Lymphocytic Leukemia
por: Susman, David, et al.
Publicado: (2021)

Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy
por: Kotchetkov, Rouslan, et al.
Publicado: (2018)

Leukoerythroblastosis with Cytopenia as an Initial Presentation of Lung Adenocarcinoma
por: Kotchetkov, Rouslan, et al.
Publicado: (2018)

Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023)

Drug Resistance in Hematological Malignancies
por: Auberger, Patrick, et al.
Publicado: (2020)

Immune Therapies for Hematologic Malignancies
por: Olnes, Matthew J.
Publicado: (2021)

Immune Microenvironment in Hematologic Malignancies
por: Arandi, Nargess, et al.
Publicado: (2023)

Molecular-Targeted Therapies for Hematologic Malignancies
por: Bunting, Kevin D., et al.
Publicado: (2012)

Secondary primary malignancies during the lenalidomide–dexamethasone regimen in relapsed/refractory multiple myeloma patients
por: Kotchetkov, Rouslan, et al.
Publicado: (2016)

The premier statistical report of hematologic malignancies in Korea
por: Kim, Hee-Je
Publicado: (2012)

Patients with hematological malignancies admitted to intensive care units: new challenges for the intensivist
por: Torres, Viviane Bogado Leite, et al.
Publicado: (2015)

Accuracy of diagnosis and individualization of treatment: the way of treating hematologic malignancies
por: Liu, Dai-Hong
Publicado: (2020)

Drug Resistance in Hematologic Malignancies: Induction Mechanisms, Genetics, and Therapeutics
por: Zhan, Fenghuang, et al.
Publicado: (2015)

Preface of the Special Issue “COVID-19 Infection and Hematological Malignancies”
por: Chen, Mingyi, et al.
Publicado: (2022)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

Chromosomal aberrations in hematological malignancies: A guide to the identification of novel oncogenes
por: Vundinti, Babu Rao, et al.
Publicado: (2011)

CXCR4 antagonists in hematologic malignancies: more than just mobilizers?
por: Jo, Deog-Yeon
Publicado: (2011)

Targeted Therapy in Hematological Malignancies: From Basic Research to Clinical Practice
por: Ma, Haiqing, et al.
Publicado: (2015)

For older adults with hematologic malignancies, a comprehensive geriatric assessment matters
por: Cordoba, Raul
Publicado: (2022)

An interview with Dan L. Longo, Section Editor of the Malignant hematological diseases section
por: Longo, Dan L
Publicado: (2013)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

SARS-CoV-2 vaccination in patients with solid tumors or hematological malignancies: Is the pandemic over for fully vaccinated patients?
por: Zojer, Niklas
Publicado: (2021)

Measuring Clinical Benefit of Treatments for Hematologic Malignancies: Critical First Steps Accomplished—What is Next?
por: Gribben, John G., et al.
Publicado: (2020)

Dilemma Concerning the Differential Diagnosis of Hematological Malignancy and Bone Metastasis Arising from Lung Cancer
por: Kaira, Kyoichi
Publicado: (2022)

Inonotosis in Patient with Hematologic Malignancy
por: Fernández-Cruz, Ana, et al.
Publicado: (2018)

Clinical Hematology International: Why a New Journal in Hematology?
por: Mohty, Mohamad, et al.
Publicado: (2019)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Carbamazepine and Hematological Malignancies
por: Yavaşoğlu, İrfan, et al.
Publicado: (2013)

Malignant benign hematology
por: Sholzberg, Michelle
Publicado: (2018)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

Autophagy in Hematological Malignancies
por: García Ruiz, Olga, et al.
Publicado: (2022)

Viral infections in patients with hematological malignancies
por: Busca, A
Publicado: (2012)

Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2012)

Prevention of Infections in Patients with Hematological Malignancies
por: Nucci, Marcio, et al.
Publicado: (2017)

COVID-19 in patients with hematologic malignancy
por: Langerbeins, Petra, et al.
Publicado: (2022)

Trends in mortality from infection among patients with hematologic malignancies: differences according to hematologic malignancy subtype
por: Yin, Xuejiao, et al.
Publicado: (2023)

Best of hematology—2021
por: Prochazka, Katharina Theresa
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mpkkqrj04puadf9fui62bc1om9